| Literature DB >> 29867323 |
Moritz Gröschel1, Dietmar Basta1, Arne Ernst1, Birgit Mazurek2, Agnieszka J Szczepek3.
Abstract
Noise that is capable of inducing the hearing loss (NIHL) has a strong impact on the inner ear structures and causes early and most obvious pathophysiological changes in the auditory periphery. Several studies indicated that intrinsic apoptotic cell death mechanisms are the key factors inducing cellular degeneration immediately after noise exposure and are maintained for days or even weeks. In addition, studies demonstrated several changes in the central auditory system following noise exposure, consistent with early apoptosis-related pathologies. To clarify the underlying mechanisms, the present study focused on the noise-induced gene and protein expression of the pro-apoptotic protease activating factor-1 (APAF1) and the anti-apoptotic B-cell lymphoma 2 related protein a1a (BCL2A1A) in the cochlear nucleus (CN), inferior colliculus (IC) and auditory cortex (AC) of the murine central auditory pathway. The expression of Bcl2a1a mRNA was upregulated immediately after trauma in all tissues investigated, whereas the protein levels were significantly reduced at least in the auditory brainstem. Conversely, acute noise has decreased the expression of Apaf1 gene along the auditory pathway. The changes in APAF1 protein level were not statistically significant. It is tempting to speculate that the acoustic overstimulation leads to mitochondrial dysfunction and induction of apoptosis by regulation of proapoptotic and antiapoptotic proteins. The inverse expression pattern on the mRNA level of both genes might reflect a protective response to decrease cellular damage. Our results indicate the immediate presence of intrinsic apoptosis following noise trauma. This, in turn, may significantly contribute to the development of central structural deficits. Auditory pathway-specific inhibition of intrinsic apoptosis could be a therapeutic approach for the treatment of acute (noise-induced) hearing loss to prevent irreversible neuronal injury in auditory brain structures and to avoid profound deficits in complex auditory processing.Entities:
Keywords: APAF1; BCL2A1A; acute noise exposure; central auditory system; noise-induced hearing loss
Year: 2018 PMID: 29867323 PMCID: PMC5954103 DOI: 10.3389/fnins.2018.00312
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Gene table RT2 PCR array.
| A01 | Mm.318925 | 9430015G10 Rik | RIKEN cDNA 9430015G10 gene | |
| A02 | Mm.1318 | Abl1 | C-abl oncogene 1, non-receptor tyrosine kinase | |
| A03 | Mm.6645 | Akt1 | Thymoma viral proto-oncogene 1 | |
| A04 | Mm.220289 | Apaf1 | Apoptotic peptidase activating factor 1 | |
| A05 | Mm.277585 | App | Amyloid beta (A4) precursor protein | |
| A06 | Mm.9852 | Atg12 | Autophagy-related 12 (yeast) | |
| A07 | Mm.272972 | Atg16l1 | Autophagy-related 16-like 1 (yeast) | |
| A08 | Mm.41775 | Atg3 | Autophagy-related 3 (yeast) | |
| A09 | Mm.22264 | Atg5 | Autophagy-related 5 (yeast) | |
| A10 | Mm.275332 | Atg7 | Autophagy-related 7 (yeast) | |
| A11 | Mm.396107 | Atp6v1g2 | ATPase, H+ transporting, lysosomal V1 subunit G2 | |
| A12 | Mm.19904 | Bax | Bcl2-associated × protein | |
| B01 | Mm.257460 | Bcl2 | B-cell leukemia/lymphoma 2 | |
| B02 | Mm.425593 | Bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | |
| B03 | Mm.238213 | Bcl2l1 | Bcl2-like 1 | |
| B04 | Mm.141083 | Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | |
| B05 | Mm.178947 | Becn1 | Beclin 1, autophagy related | |
| B06 | Mm.335659 | Birc2 | Baculoviral IAP repeat-containing 2 | |
| B07 | Mm.2026 | Birc3 | Baculoviral IAP repeat-containing 3 | |
| B08 | Mm.210125 | Bmf | Bcl2 modifying factor | |
| B09 | Mm.1051 | Casp1 | Caspase 1 | |
| B10 | Mm.3921 | Casp2 | Caspase 2 | |
| B11 | Mm.34405 | Casp3 | Caspase 3 | |
| B12 | Mm.281379 | Casp6 | Caspase 6 | |
| C01 | Mm.35687 | Casp7 | Caspase 7 | |
| C02 | Mm.88829 | Casp9 | Caspase 9 | |
| C03 | Mm.67659 | Ccdc103 | Coiled-coil domain containing 103 | |
| C04 | Mm.271833 | Cd40 | CD40 antigen | |
| C05 | Mm.4861 | Cd40lg | CD40 ligand | |
| C06 | Mm.336848 | Cflar | CASP8 and FADD-like apoptosis regulator | |
| C07 | Mm.41687 | Commd4 | COMM domain containing 4 | |
| C08 | Mm.236553 | Ctsb | Cathepsin B | |
| C09 | Mm.3619 | Ctss | Cathepsin S | |
| C10 | Mm.24282 | Cyld | Cylindromatosis (turban tumor syndrome) | |
| C11 | Mm.431316 | Defb1 | Defensin beta 1 | |
| C12 | Mm.222473 | Dennd4a | DENN/MADD domain containing 4A | |
| D01 | Mm.41433 | Dffa | DNA fragmentation factor, alpha subunit | |
| D02 | Mm.250414 | Dpysl4 | Dihydropyrimidinase-like 4 | |
| D03 | Mm.260943 | Eif5b | Eukaryotic translation initiation factor 5B | |
| D04 | Mm.9213 | Esr1 | Estrogen receptor 1 (alpha) | |
| D05 | Mm.1626 | Fas | Fas (TNF receptor superfamily member 6) | |
| D06 | Mm.3355 | Fasl | Fas ligand (TNF superfamily, member 6) | |
| D07 | Mm.32926 | Foxi1 | Forkhead box I1 | |
| D08 | Mm.4793 | Gaa | Glucosidase, alpha, acid | |
| D09 | Mm.72235 | Gadd45a | Growth arrest and DNA-damage-inducible 45 alpha | |
| D10 | Mm.484118 | Galnt5 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 | |
| D11 | Mm.439649 | Grb2 | Growth factor receptor bound protein 2 | |
| D12 | Mm.45272 | Hspbap1 | Hspb associated protein 1 | |
| E01 | Mm.209071 | Htt | Huntingtin | |
| E02 | Mm.240327 | Ifng | Interferon gamma | |
| E03 | Mm.268521 | Igf1 | Insulin-like growth factor 1 | |
| E04 | Mm.275742 | Igf1r | Insulin-like growth factor I receptor | |
| E05 | Mm.4946 | Ins2 | Insulin II | |
| E06 | Mm.29938 | Irgm1 | Immunity-related GTPase family M member 1 | |
| E07 | Mm.306870 | Jph3 | Junctophilin 3 | |
| E08 | Mm.252514 | Kcnip1 | Kv channel-interacting protein 1 | |
| E09 | Mm.241355 | Mag | Myelin-associated glycoprotein | |
| E10 | Mm.196239 | Map1lc3a | Microtubule-associated protein 1 light chain 3 alpha | |
| E11 | Mm.21495 | Mapk8 | Mitogen-activated protein kinase 8 | |
| E12 | Mm.1639 | Mcl1 | Myeloid cell leukemia sequence 1 | |
| F01 | Mm.256765 | Nfkb1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105 | |
| F02 | Mm.475715 | Nol3 | Nucleolar protein 3 (apoptosis repressor with CARD domain) | |
| F03 | Mm.377733 | Olfr1404 | Olfactory receptor 1404 | |
| F04 | Mm.277779 | Parp1 | Poly (ADP-ribose) polymerase family, member 1 | |
| F05 | Mm.281482 | Parp2 | Poly (ADP-ribose) polymerase family, member 2 | |
| F06 | Mm.194127 | Pik3c3 | Phosphoinositide-3-kinase, class 3 | |
| F07 | Mm.227506 | Pvr | Poliovirus receptor | |
| F08 | Mm.26994 | Rab25 | RAB25, member RAS oncogene family | |
| F09 | Mm.394280 | Rps6kb1 | Ribosomal protein S6 kinase, polypeptide 1 | |
| F10 | Mm.291525 | S100a7a | S100 calcium binding protein A7A | |
| F11 | Mm.17484 | Snca | Synuclein, alpha | |
| F12 | Mm.34342 | Spata2 | Spermatogenesis associated 2 | |
| G01 | Mm.40828 | Sqstm1 | Sequestosome 1 | |
| G02 | Mm.70781 | Sycp2 | Synaptonemal complex protein 2 | |
| G03 | Mm.99793 | Tmem57 | Transmembrane protein 57 | |
| G04 | Mm.1293 | Tnf | Tumor necrosis factor | |
| G05 | Mm.193430 | Tnfrsf10b | Tumor necrosis factor receptor superfamily, member 10b | |
| G06 | Mm.15383 | Tnfrsf11b | Tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) | |
| G07 | Mm.1258 | Tnfrsf1a | Tumor necrosis factor receptor superfamily, member 1a | |
| G08 | Mm.3399 | Traf2 | Tnf receptor-associated factor 2 | |
| G09 | Mm.222 | Trp53 | Transformation related protein 53 | |
| G10 | Mm.37667 | Txnl4b | Thioredoxin-like 4B | |
| G11 | Mm.271898 | Ulk1 | Unc-51 like kinase 1 (C. elegans) | |
| G12 | Mm.259879 | Xiap | X-linked inhibitor of apoptosis | |
| H01 | Mm.328431 | Actb | Actin, beta (housekeeping gene 1) | |
| H02 | Mm.163 | B2m | Beta-2 microglobulin (housekeeping gene 2) | |
| H03 | Mm.343110 | Gapdh | Glyceraldehyde-3-phosphate dehydrogenase (housekeeping gene 3) | |
| H04 | Mm.3317 | Gusb | Glucuronidase, beta (housekeeping gene 4) | |
| H05 | Mm.2180 | Hsp90ab1 | Heat shock protein 90 alpha (cytosolic), class B member 1 (housekeeping gene 5) | |
| H06 | N/A | MGDC | Mouse Genomic DNA Contamination Control | |
| H07 | N/A | RTC | Reverse Transcription Control | |
| H08 | N/A | RTC | Reverse Transcription Control | |
| H09 | N/A | RTC | Reverse Transcription Control | |
| H10 | N/A | PPC | Positive PCR Control | |
| H11 | N/A | PPC | Positive PCR Control | |
| H12 | N/A | PPC | Positive PCR Control |
Figure 1Relative mRNA expression of Bcl2a1a. Presented are ΔCq values (mean ± S.D.) in the cochlear nucleus (CN), inferior colliculus (IC) and auditory cortex (AC) of the mouse central auditory pathway immediately after noise trauma compared to unexposed controls. Asterisks indicate significant differences between control and trauma group (*p < 0.05; **p < 0.01; ***p < 0.001).
Figure 2Relative mRNA expression of Apaf1. Presented are ΔCq values (mean ± S.D.) in the cochlear nucleus (CN), inferior colliculus (IC) and auditory cortex (AC) of the mouse central auditory pathway immediately after noise trauma compared to unexposed controls. Asterisks indicate significant differences between control and trauma group (**p < 0.01; ***p < 0.001; n.s., no significant difference between groups).
Figure 3Relative protein amounts of BCL2A1A. Presented are ratios to respective controls from the Western blot experiments (mean ± S.D.) in the cochlear nucleus (CN), inferior colliculus (IC) and auditory cortex (AC) of the mouse central auditory pathway immediately after noise trauma compared to unexposed controls. Asterisks indicate significant differences between control and trauma group (**p < 0.01; n.s., no significant difference between groups).
Figure 4Relative protein amounts of APAF1. Presented are ratios to the respective controls from the Western blot experiments (mean ± S.D.) in the cochlear nucleus (CN), inferior colliculus (IC) and auditory cortex (AC) of the mouse central auditory pathway immediately after noise trauma compared to unexposed controls (n.s., no significant difference between groups).